Please use this identifier to cite or link to this item:
Title: Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection
Authors: Parrot, Tiphaine
Healy, Katie
Boulouis, Caroline
Sobkowiak, Michal J.
Leeansyah, Edwin 
Aleman, Soo
Bertoletti, Antonio 
Chen, Margaret Sallberg
Sandberg, Johan K.
Issue Date: 8-Mar-2021
Publisher: American Society for Clinical Investigation
Citation: Parrot, Tiphaine, Healy, Katie, Boulouis, Caroline, Sobkowiak, Michal J., Leeansyah, Edwin, Aleman, Soo, Bertoletti, Antonio, Chen, Margaret Sallberg, Sandberg, Johan K. (2021-03-08). Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection. JCI Insight 6 (5) : e140074. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Progress in our understanding of MR1-restricted mucosa-associated invariant T (MAIT) cells has raised interest in harnessing these cells for immunotherapy. The innate-like response characteristics, abundance in the blood, donor-unrestricted nature, and tropism for tissues make MAIT cells suitable candidates for adoptive cell transfer therapies. However, reliable methods and tools to utilize MAIT cells in such approaches are lacking. Here, we established methodology for efficient expansion of human MAIT cells in culture with high purity and yield, while preserving their functional response toward their natural ligand and increasing their cytotoxic potential. The cultured MAIT cells retained their effector memory characteristics without signs of terminal differentiation and expressed a more diverse set of chemokine receptors, potentially widening their already broad tissue tropism. To investigate the potential of MAIT cells in a context outside their main role in controlling bacterial infection, we engineered cultured MAIT cells with a new TCR specificity to mediate effective antiviral HLA class I–restricted effector function. In summary, we developed robust and effective methodology for the expansion of human MAIT cells with enhanced cytolytic capacity and for their engineering with a new specificity. These findings form a basis for the development of MAIT cells as a platform for adoptive immunotherapy. Copyright: © 2021, Parrot et al.
Source Title: JCI Insight
ISSN: 2379-3708
DOI: 10.1172/jci.insight.140074
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1172_jci_insight_140074.pdf4.54 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons